Reduction of Yellow Fever Virus Mouse Neurovirulence by Immunization with a Bacterially Synthesized Non-structural Protein (NS1) Fragment

References

1. COHEN S. N., CHANG A. C. Y., HSU C. L. 1972; Non-chromosomal antibiotic resistance in bacteria: genetic transformation of Escherichia coli by R factor DNA. Proceedings of the National Academy of Sciences, U.S.A 69:2110–2114
   [Google Scholar]
2. GOULD E. A., BUCKLEY A., BARRETT A. D. T., CAMMACK N. 1986; Neutralizing (54K) and non-neutralizing (54K and 48K) monoclonal antibodies against structural and non-structural yellow fever virus proteins confer immunity in mice. Journal of General Virology 67:591–595
   [Google Scholar]
3. GUERRY P., LEBLANC D. J., FALKOW S. 1973; General method for the isolation of plasmid deoxyribonucleic acid. Journal of Bacteriology 116:1064–1066
   [Google Scholar]
4. HOLMES D. S., QUIGLEY N. 1981; A rapid boiling method for preparation of bacterial plasmids. Analytical Biochemistry 114:193–197
   [Google Scholar]
5. LAEMMLI U. K. 1970; Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, London 227:680–685
   [Google Scholar]
6. LIPRANDI F. 1981; Isolation of plaque variants differing in virulence from the 17D strain of yellow fever virus. Journal of General Virology 56:363–370
   [Google Scholar]
7. MANIATIS T., FRITSCH E. F., SAMBROOK J. 1982 Molecular Cloning: A Laboratory Manual New York: Cold Spring Harbor Laboratory;
   [Google Scholar]
8. MATLASHEWSKI G., BANKS L., WU-LIAO J., SPENCE P., PIM D., CRAWFORD L. 1986; The expression of human papillomavirus type 18 E6 protein in bacteria and the production of anti-E6 antibodies. Journal of General Virology 67:1909–1916
   [Google Scholar]
9. RICE C. M., LENCHES E. M., EDDY S. R., SHIN S. J., SHEETS R. L., STRAUSS J. H. 1985; Nucleotide sequence of yellow fever virus: implications for flavivirus gene expression and evolution. Science 229:726–733
   [Google Scholar]
10. RUTHER U., MULLER-HILL B. 1983; Easy identification of cDNA clones. EMBO Journal 2:1791–1794
    [Google Scholar]
11. SCHLESINGER J. J., BRANDRISS M. W., WALSH E. E. 1985; Protection against yellow fever virus encephalitis in mice by passive transfer of monoclonal antibodies to the non-structural glycoprotein gp48 and by active immunisation by gp48. Journal of Immunology 135:2805–2809
    [Google Scholar]
12. SCHLESINGER J. J., BRANDRISS M. W., CROPP C. B., MONATH T. P. 1986; Protection against yellow fever virus in monkeys by immunisation with yellow fever virus non-structural NS1. Journal of Virology 60:1153–1155
    [Google Scholar]
13. SCHLESINGER J. I., BRANDRISS M. W., WALSH E. E. 1987; Protection of mice against dengue 2 virus encephalitis by immunization with the dengue 2 virus non-structural glycoprotein NS1. Journal of General Virology 68:853–857
    [Google Scholar]
14. WATSON R. J., WEIS J. H., SALSTROM J. S., ENQUIST L. W. 1985 Expression of herpes simplex type 1 and type 2 glycoprotein D genes using the Escherichia coli lac promoter. Recombinant DNA Research and Virus327–352 Edited by Becker Y. Boston: Martinus Nijhoff;
    [Google Scholar]
15. WESTAWAY E. G., GOODMAN M. R. 1987; Variation in distribution of the three flavivirus specified glycoproteins detected by immunofluorescence in infected Vero cells. Archives of Virology 94:215–228
    [Google Scholar]
16. WESTAWAY E. G., BRINTON M. A., GAIDAMOVICH S. Y., HORZINEK M. C, IGARISHI A., KÄÄRIAINEN L., LVOV D. K., PORTERFIELD J. S., RUSSELL P. K., TRENT D. W. 1985; Flaviviridae. Intervirology 24:183–192
    [Google Scholar]